SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast Cancer Article

Open Access

author list

  • van Reesema, Lauren L. Siewertsz, Zheleva, Vasilena, Winston, Janet S., Jansen, Rick J., O'Connor, Carolyn F., Isbell, Andrew J., Bian, Minglei, Qin, Rui, Bassett, Patricia T., Hinson, Virginia J., Dorsch, Kimberly A., Kirby, Brad W., Van Sciver, Robert E., Tang-Tan, Angela M., Harden, Elizabeth A., Chang, David Z., Allen, Cynthia A., Perry, Roger R., Hoefer, Richard A., Tang, Amy H.

authors

publication date

  • September 1, 2016

webpage

published in

author keyword

  • And prognostic biomarkers
  • Clinicopathological predictors
  • Locally advanced and metastatic breast cancer
  • Needle biopsies
  • Neoadjuvant systemic therapies
  • SIAH E3 ligase
  • The RAS pathway activation in breast cancer

category

keywords

  • And prognostic biomarkers
  • Clinicopathological predictors
  • Locally advanced and metastatic breast cancer
  • Needle biopsies
  • Neoadjuvant systemic therapies
  • SIAH E3 ligase
  • The RAS pathway activation in breast cancer

start page

  • 183

end page

  • 198

volume

  • 11